ArticleCureus2025
A Challenging Diagnosis of Papillary Thyroid Carcinoma Arising From Malignant Struma Ovarii.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Sonographic and Clinicopathological Characterization of Struma Ovarii: A Retrospective Analysis for Enhanced Preoperative DiagnosisCurrent medical imaging · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ovarian teratomas are a common type of ovarian neoplasm. These tumors have various histologic subtypes, including struma ovarii (SO), which is considered a rare tumor. SO is characterized by the presence of thyroid tissue within its components. Since it contains thyroid cells, it can produce thyroid hormones, leading to thyrotoxicosis, or it can transform into malignant tissue, resulting in thyroid carcinoma, with papillary thyroid cancer being the most common histologic subtype. We present the case of a 46-year-old woman who experienced abdominal pain and was found to have an ovarian mass with malignant features. Excision of the ovaries revealed SO with well to moderately differentiated papillary thyroid cancer. The patient's thyroid function tests were normal, and no distant metastases were found. She was started on a small dose of supplemental thyroid hormone to suppress thyroid-stimulating hormone (TSH) to a low normal level. The highest incidence of malignant struma ovarii (MSO) occurs in the fifth decade of life. The symptoms are usually vague and nonspecific, and the diagnosis is typically made after excision of the adnexal mass. The management of SO is primarily surgical, which is curative in most cases, but should be preceded by tumor staging and postoperative thyroid hormone suppression, along with surveillance using imaging and thyroid biochemical markers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.